You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase I therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Periodontal Pocket, Periodontitis Trial in Naples, Napoli (SRP and concomitant insertion of PRF membrane, SRP)

Completed
  • Periodontal Pocket
  • Periodontitis
  • SRP and concomitant insertion of PRF membrane
  • SRP
  • Naples, Italy
  • +1 more
Jun 16, 2023

Solid Tumors Trial in Guangzhou (MASCT-I injection)

Completed
  • Solid Tumors
  • MASCT-I injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 25, 2023

Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • With Positive PSMA Expression at Tumor Sites
  • 177Lu-PSMA-1 (radiopharmaceutical)
  • (no location specified)
Sep 26, 2023

Prostatic Tumors, Castration-Resistant Trial in Rotterdam (Radionuclide Therapy)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Radionuclide Therapy
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Jun 5, 2023

Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

Not yet recruiting
  • Neoplasms
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2023

Periodontitis Trial in Istanbul (Initial periodontal treatment)

Completed
  • Periodontitis
  • Initial periodontal treatment
  • Istanbul, Turkey
    Biruni University
Aug 12, 2022

Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended

Not yet recruiting
  • Cancer
  • +3 more
  • 177Lu-PSMA-I&T - escalating renal absorbed dose
  • 177Lu-PSMA-I&T - recommended phase 2 regime
  • (no location specified)
Jun 14, 2023

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Sentinel Lymph Node Biopsy (SLNB)
  • +7 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 2, 2023

Hepatocellular Carcinoma Trial in Jakarta Pusat (Autologous Natural Killer Cell Therapy, Clinimacs Plus)

Recruiting
  • Hepatocellular Carcinoma
  • Autologous Natural Killer Cell Therapy
  • Clinimacs Plus
  • Jakarta Pusat, Jakarta, Indonesia
    Cipto Mangunkusumo General Hospital
Sep 24, 2023

Pancreatic Cancer Trial (BNT321 Dose Level 1, BNT321 Dose Level 2, mFOLFIRINOX)

Not yet recruiting
  • Pancreatic Cancer
  • BNT321 Dose Level 1
  • +3 more
  • (no location specified)
Sep 29, 2023

AminoMedixTM for Kidney Protection During Radionuclide Therapy

Completed
  • Radiation Nephropathy
    • (no location specified)
    Mar 22, 2023

    Gastroesophageal Adenocarcinoma Trial (toripalimab FOLFOX)

    Not yet recruiting
    • Gastroesophageal Adenocarcinoma
    • toripalimab FOLFOX
    • (no location specified)
    Aug 3, 2023

    Spinal Metastases Trial in Lake Success (Kypho-IORT)

    Completed
    • Spinal Metastases
    • Kypho-IORT
    • Lake Success, New York
      Northwell Health
    Oct 31, 2022

    Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)

    Not yet recruiting
    • Extensive Stage Lung Small Cell Carcinoma
    • Stage IV Lung Cancer
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Oct 25, 2023

    Advanced Breast Cancer, Advanced Lung Cancer Trial (Tumor-infiltrating lymphocytes, IL-2)

    Not yet recruiting
    • Advanced Breast Cancer
    • Advanced Lung Cancer
    • Tumor-infiltrating lymphocytes
    • IL-2
    • (no location specified)
    Oct 26, 2023

    Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Cytokine Induced Memory-like Natural Killer Cells
    • Interleukin-2
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2023

    Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (225Ac-PSMA-R2, 68Ga-PSMA-R2)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Aug 8, 2023

    Locally Advanced Pancreatic Cancer Trial in Washington, Baltimore (Gemcitabine, Hypofractionated Ablative Proton Therapy)

    Recruiting
    • Locally Advanced Pancreatic Cancer
    • Washington, District of Columbia
    • +1 more
    Oct 10, 2022

    Breast Cancer Trial in Tianjin (Dalpiciclib, Pyrotinib, Fulvestrant)

    Not yet recruiting
    • Breast Cancer
    • Tianjin, China
      Tianjin Cancer Hospital
    Mar 28, 2023

    Mucopolysaccharidosis I Trial in Wuhan (Laronidase)

    Recruiting
    • Mucopolysaccharidosis I
    • Wuhan, China
      Investigational Site Number :1560001
    Jan 15, 2023

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

    Recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +3 more
    • Best Practice
    • +5 more
    • Ames, Iowa
      Mary Greeley Medical Center
    Jan 24, 2023

    Kidney Cancer Trial in New York (Iodine-131 radiolabeled chimeric mAb G250 (131I-cG250))

    Completed
    Has Results
    • Kidney Cancer
    • Iodine-131 radiolabeled chimeric monoclonal antibody G250 (131I-cG250)
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022

    Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell Trial in United Kingdom (ALETA-001)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • +4 more
    • Birmingham, United Kingdom
    • +5 more
    Sep 18, 2023

    Age-Related Macular Degeneration Trial (KH631)

    Not yet recruiting
    • Age-Related Macular Degeneration
    • (no location specified)
    Dec 10, 2022

    Lysosomal Storage Disease, Metachromatic Leukodystrophy Trial in Milan (OTL-200 Gene Therapy)

    Active, not recruiting
    • Lysosomal Storage Disease
    • Metachromatic Leukodystrophy
    • OTL-200 Gene Therapy
    • Milan, Italy
      Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR
    Nov 4, 2022